Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2019

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. ACN
7. NVDA
8. BLZE
9. IBM
10. PRIM

Go back to Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2019

Emergent BioSolutions (EBS) Misses Q2 EPS by 5c

August 1, 2019 5:06 PM EDT

Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.12, $0.05 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $243.2 million versus the consensus estimate of $212.06 million.

For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.

... More